| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.063 | 0.6 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.084 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |